These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 2474107)

  • 1. Role of kallikrein-kinin system in the hypotensive mechanisms of converting enzyme inhibitors in essential hypertension.
    Iimura O; Shimamoto K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S63-6. PubMed ID: 2474107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of renin-angiotensin and kallikrein-kinin systems on the mechanism of the hypotensive effects of converting enzyme inhibitor, alacepril.
    Tanaka S; Shimamoto K; Ando T; Nakahashi Y; Ura N; Hosoda S; Ishida H; Yamaji I; Yokoyama T; Masuda A
    Clin Exp Hypertens A; 1987; 9(2-3):605-9. PubMed ID: 3038424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of the hypotensive effect of captopril (converting enzyme inhibitor) with special reference to the kallikrein-kinin and renin-angiotensin systems.
    Iimura O; Shimamoto K; Tanaka S; Hosoda S; Nishitani T; Ando T; Masuda A
    Jpn J Med; 1986 Feb; 25(1):34-9. PubMed ID: 3520064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors and the kallikrein-kinin system.
    Shimamoto K; Matsuki T; Iimura O
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S83-90. PubMed ID: 1697368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo concentrations of kinins and angiotensins.
    Shimamoto K; Nakagawa M; Iimura O
    Horm Metab Res Suppl; 1990; 22():75-9. PubMed ID: 2143993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute antihypertensive effect of captopril in hypertensive patients: with special reference to kallikrein-kinin system].
    Mizuno K; Gotoh M; Haruyama K; Hashimoto S; Toki T; Matsui J; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1620-9. PubMed ID: 6363144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats.
    Yasujima M; Abe K; Kasai Y; Tanno M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
    Clin Exp Hypertens A; 1984; 6(6):1207-25. PubMed ID: 6086184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
    Clappison BH; Anderson WP; Johnston CI
    Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.
    Yasujima M; Abe K; Tanno M; Omata K; Yoshinaga K
    Jpn Circ J; 1984 Feb; 48(2):173-9. PubMed ID: 6321815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the renin-angiotensin-aldosterone and kallikrein-kinin systems in the control of fluid and electrolyte metabolism, renal function, and arterial blood pressure.
    McCaa RE
    Clin Exp Hypertens A; 1982; 4(9-10):1593-611. PubMed ID: 6754146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of the renin-angiotensin system and kallikrein-kinin system to sodium and converting enzyme inhibitor (SQ 14,225).
    Matthews PG; Johnston CI
    Adv Exp Med Biol; 1979; 120B():447-57. PubMed ID: 390990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system.
    Filep J; Rigter B; Földes-Filep E
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):222-7. PubMed ID: 2441174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered blood pressure and renin responses to converting enzyme inhibition after aprotinin-induced kallikrein-kinin-system blockade.
    Overlack A; Stumpe KO; Kühnert M; Heck I
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():129s-132s. PubMed ID: 6160938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal kallikrein-kinin system and control of blood pressure (author's transl)].
    Distler A; Wolff HP
    Klin Wochenschr; 1979 Oct; 57(19):1037-45. PubMed ID: 392177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
    Nolly H; Miatello R; Damiani MT; Abate CD
    Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.
    Johnston CI; Clappison B; McGrath BP; Matthews PG; Millar JA; Anderson WP
    Prog Biochem Pharmacol; 1980; 17():123-33. PubMed ID: 6259649
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of kinin and renal ANG II blockade in acute effects of ACE inhibitors in low-renin hypertension.
    Naitoh M; Suzuki H; Arakawa K; Matsumoto A; Ichihara A; Matsuda H; Kubota E; Murakami M; Nakamoto H; Saruta T
    Am J Physiol; 1997 Feb; 272(2 Pt 2):H679-87. PubMed ID: 9124424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.